ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 185 filers reported holding ASCENDIS PHARMA A/S in Q3 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,795,798 | -22.7% | 232,762 | -26.3% | 0.01% | -16.7% |
| Q2 2023 | $28,202,644 | +7.2% | 315,996 | +28.8% | 0.01% | 0.0% |
| Q1 2023 | $26,313,779 | -14.0% | 245,419 | -2.1% | 0.01% | -14.3% |
| Q4 2022 | $30,611,883 | +13.4% | 250,650 | -4.1% | 0.01% | 0.0% |
| Q3 2022 | $26,997,000 | +7.6% | 261,441 | -3.2% | 0.01% | +16.7% |
| Q2 2022 | $25,094,000 | -26.1% | 269,946 | -6.7% | 0.01% | -14.3% |
| Q1 2022 | $33,958,000 | +5.2% | 289,344 | +20.5% | 0.01% | +16.7% |
| Q4 2021 | $32,294,000 | -16.3% | 240,046 | -0.9% | 0.01% | -25.0% |
| Q3 2021 | $38,593,000 | +11.6% | 242,133 | -7.9% | 0.01% | +14.3% |
| Q2 2021 | $34,594,000 | +2.1% | 262,970 | +0.1% | 0.01% | 0.0% |
| Q1 2021 | $33,872,000 | +25.3% | 262,814 | +62.2% | 0.01% | +16.7% |
| Q4 2020 | $27,023,000 | +15.1% | 162,024 | +6.5% | 0.01% | 0.0% |
| Q3 2020 | $23,486,000 | +15.9% | 152,193 | +11.1% | 0.01% | +20.0% |
| Q2 2020 | $20,268,000 | +41.5% | 137,037 | +7.7% | 0.01% | 0.0% |
| Q1 2020 | $14,326,000 | -23.2% | 127,217 | -5.1% | 0.01% | 0.0% |
| Q4 2019 | $18,658,000 | +141.3% | 134,117 | +8.7% | 0.01% | +150.0% |
| Q4 2018 | $7,732,000 | – | 123,415 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 7,387,900 | $1,177,557,000 | 16.32% |
| Q Global Advisors, LLC | 66,714 | $10,634,000 | 8.85% |
| Ghost Tree Capital, LLC | 120,000 | $19,127,000 | 5.59% |
| Vivo Capital, LLC | 760,606 | $121,233,000 | 5.44% |
| Spyglass Capital Management LLC | 1,378,887 | $219,781,000 | 5.04% |
| Avoro Capital Advisors LLC | 1,980,000 | $315,592,000 | 4.96% |
| Eversept Partners, LP | 445,203 | $70,960,906 | 4.93% |
| Sofinnova Investments, Inc. | 499,824 | $79,667,000 | 4.72% |
| Eventide Asset Management | 1,748,648 | $278,717,000 | 3.68% |
| Baker Brothers Advisors | 4,541,604 | $723,886,000 | 3.18% |